Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japan Orders New Tests on Bird Flu Drug (Japan)

This article was originally published in PharmAsia News

Executive Summary

Japan's Health Ministry has advised Roche and Chugai Pharmaceutical to investigate whether there is a link between the avian flu drug Tamiflu and delusional behavior. The companies, which partner in marketing Tamiflu in Japan, will begin clinical trials with between 12 and 30 human subjects, and also toxicity studies, to investigate this. Chugai officials say research results should be available at the end of 2007, and Roche says no evidence exists establishing a link between Tamiflu and delusion. Since 2001 when Tamiflu began to sell in Japan, over 1,300 people have demonstrated neuropsychiatric symptoms, and 71 people died while taking it. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC066301

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel